Abstract Large segmental bone defects resulting from trauma, tumor resection, infection, or congenital abnormalities often exceed the innate regenerative capacity of bone, necessitating effective therapeutic strategies. Conventional treatments, such as autografts and allografts, are associated with significant limitati...
G. Sabarees, Sivakumar Kanmani, S. Kowsalya et al.· International Journal of Pol...· 0 citations
INTRODUCTION
The design of novel therapeutic entities for neurodegenerative diseases, particularly Parkinson's disease, remains a major challenge in medicinal chemistry. Current treatment strategies primarily rely on symptomatic management, often involving levodopa in combination with catechol-O-methyltransferase (COMT...
Keerthana Dhinakaran, Amuthulakshmi Sivaperuman, Ramalakshmi Natarajan et al.· Current Topics in Medicinal...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.